Scientists at the Icahn School of Medicine at Mount Sinai have identified an important immune response that helps explain why ...

Opportunities include the growing demand for scalable solutions to support the burgeoning cell and gene therapy pipeline, ...

Stem cell therapy is an emerging treatment for type 2 diabetes. Although it’s not yet FDA-approved in the United States, it is a rapidly expanding and promising field of research. Stem cells are ...

One challenge of using cell therapy to treat type 1 diabetes is that this approach requires chronic suppression of the immune system to prevent rejection of donor cells. A Vertex Pharmaceuticals ...

Scientists at the Icahn School of Medicine at Mount Sinai have identified an important immune response that helps explain why ...

A Vertex Pharmaceuticals cell therapy for type 1 diabetes is enabling patients to produce insulin, eliminating the need for additional insulin therapy in the vast majority of participants in a key ...

Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach Liz on Signal at LizC.22. Twelve people with type 1 diabetes who received ...

Researchers at Stanford found a way to cure or prevent Type 1 diabetes in mice using a combined blood stem cell and islet cell transplant. The procedure creates a hybrid immune system that stops ...

Stem cell therapy uses stem cells or their derivatives to repair and regenerate tissues that have been diseased, damaged, or ...

Integration of targeted therapies and immunotherapies offers new hope, enhancing survival rates and quality of life. Patients with mantle cell lymphoma experienced better survival rates when treated ...